Exhale

The official blog of the Lung Institute.

This Week in Lung Disease: Think Again ‘Healthy Smokers’; Avoid Falls and Landfills

23 Jun 2016
| Under Lifestyle | Posted by | 6 Comments
This week in lung disease

There are many places to get news online, such as blogs, websites, some random e-mail chain letter your cousin sent you. That’s why each week, the Lung Institute searches the internet to find trending news stories relating to lung disease, cellular therapy and lung health. Check out the latest edition of This Week in Lung Disease news.

‘Healthy Smoker’? Think Again

If you, or someone you know who smokes think they’ve dodged the lung disease bullet, think again. According to two new studies, spirometry tests may not be able to detect all serious abnormalities in current and former smokers.

A spirometry test, which measures how much air a person can inhale and how quickly they can exhale, may miss underlying conditions for people not experiencing airflow obstructions. For those currently smoking, this may give them the notion that they’re ok and continue smoking – which is not the case. The researchers projected that there are 35 million current or former smokers older than 55 in the United States with unrecognized smoking-caused lung diseases.

Still, the best thing a smoker to do is quit immediately, and for former smokers to see their primary care doctor regularly to monitor their lung health.

To read more about this story, go to The New York Times website.

E-Cig Flavorings May Cause Severe Lung Disease

Those sweet smelling vapor clouds may not be as good for you as previously thought. A recent study has found that chemical flavorings used in electronic cigarettes, or E-cigs, can cause severe lung disease. Harvard researchers looked at 51 types of favored e-cigs and refill liquid for chemicals diacetyl, acetoin and 2,3-pentanedione.

Diacetycl, in particular, has been linked to a severe lung disease known as “popcorn lung” which affected workers who inhaled artificial butter fumes at microwavable popcorn factories. Out of the 51 flavors tested, 47 contained at least one of those chemicals.

To read more about this story, go to CBS News.

Living Near Landfills Gets Even Worse

Scientists have found a new reason to hate living near a dump. Scientists claim that living near landfills may increase the risk of lung cancer and other lung diseases. The study, published in the International Journal of Epidemiology claimed that homeowners and children living within three miles of the landfills were more susceptible to being exposed to toxic pollutants.

For more information, check out the Telegraph.

For Older Adults, Don’t Fall for This One

Recently, the Huffington Post published an in-depth article on “How to Prevent Falls in Older Adults”, which offered some great advice. According to the Centers for Disease Control and Prevention (CDC), one out of three people age 65 or older falls each year, and more than 700,000 are hospitalized due to the fall.

Some of the ways to avoid serious falls is to be mindful of visual and hearing impairments, side effects due to medication and hazards around the house.

For the full list of suggestions, check out the post here.

Keep checking-in with us for the latest lung disease news. If you or someone you know has a chronic lung disease, remember there is hope. At the Lung Institute, we specialize in cellular therapys for those with lung diseases such as COPD, pulmonary fibrosis and interstitial lung disease. For more information about the Lung Institute or cellular therapy, please contact one of our patient coordinators or call (800) 729-3065 today.

* Every patient is given a Patient Satisfaction Survey shortly after treatment. Responses to the 11-question survey are aggregated to determine patient satisfaction with the delivery of treatment.

^ Quality of Life Survey data measured the patient’s self-assessed quality of life and measurable quality of improvement at three months of COPD patients.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.

Each patient is different. Results may vary.